FTC strikes back at misconduct allegations
Friday, 23 July 2010
Ron Knox
The US Federal Trade Commission has fought back against charges that it acted improperly in investigating an alleged pay-for-delay pharmaceutical deal by disclosing confidential business secrets and attempting to broker a behind-the-scenes deal between two drug makers.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top